Peptides and Groin Pulls: Research on Recovery

A groin pull — or adductor strain — is one of those injuries that sounds minor but can keep an athlete out for weeks or months if not managed properly. The adductor muscles run along the inside of the thigh and are responsible for bringing the legs together. Sports like soccer, hockey, basketball, and martial arts put heavy strain on these muscles during lateral cuts and explosive movements.

Anatomy of a Groin Pull

The adductor group consists of five muscles: the adductor longus, adductor brevis, adductor magnus, gracilis, and pectineus. A groin pull is typically a strain of one or more of these muscles, usually at or near the point where they attach to the pelvis or inner thigh bone.

Like all muscle strains, groin pulls are graded on severity:

• Grade 1: Microscopic tears, mild pain, minimal functional loss
• Grade 2: Partial tear, significant pain, reduced strength and range of motion
• Grade 3: Complete rupture, severe pain, significant functional impairment

The challenge with adductor injuries is that the muscles are used in nearly every movement — sitting, walking, changing direction. Complete rest is almost impossible, which means healing can be slow and re-injury risk is high.

BPC-157 and Adductor Repair

BPC-157 is the most well-studied peptide for acute soft tissue injury. It is derived from a protective protein in gastric juice and has been shown in multiple animal studies to accelerate healing in muscle, tendon, and ligament tissue.

For groin pulls specifically, the most relevant BPC-157 research findings include:

• Accelerated repair of muscle fiber tears in rodent models
• Upregulation of growth factors that drive tissue regeneration
• Reduction in scar tissue formation — particularly important for maintaining muscle elasticity
• Enhanced tendon-to-bone attachment healing at injury margins

Given that adductor injuries often involve the musculotendinous junction — where muscle meets tendon — BPC-157’s effectiveness across both tissue types is particularly relevant to this injury type.

View BPC-157 →

TB-500 and the Recovery Environment

TB-500 works differently from BPC-157. Where BPC-157 drives growth factor production and fibroblast activity, TB-500 focuses on cell migration, angiogenesis, and anti-inflammatory signaling. These are complementary mechanisms.

In groin pull recovery research models, TB-500’s relevant properties include:

• Directing repair cells to the injury site faster
• Reducing the inflammatory cascade that causes excessive scarring
• Promoting new capillary formation to improve oxygen and nutrient delivery
• Reducing fibrous adhesions between healing tissue planes

The adductor muscles lie between multiple tissue layers. Adhesions between these layers can restrict movement and cause chronic tightness even after the primary injury heals. TB-500’s effect on reducing fibrous adhesion formation is directly relevant here.

View TB-500 →

Research Protocol Considerations

In research settings exploring these peptides for soft tissue injuries, timing of administration relative to injury is often a variable. Animal studies suggest earlier administration following injury produces better outcomes, though this has not been rigorously tested in human clinical trials for groin injuries specifically.

Researchers also consider whether systemic or localized administration produces different tissue-level outcomes. Most published animal studies use systemic routes, with some exploring local injection protocols for targeted tissue repair.

What Is Not Yet Known

There are no published clinical trials specifically on peptides for groin pull recovery. All evidence is extrapolated from animal models of related soft tissue injuries. The biological mechanisms are plausible and consistent with the injury type, but translation to human clinical outcomes has not been formally established.

Summary of Key Research References

Written by the NorthPeptide Research Team